Elevated maternal body mass index and excessive weight gain during pregnancy increase the risk of early-onset CVD in offspring.

Thomas Nero, MD, host of the Future Pulse Cardiology podcast, has partnered with Cardiology Advisor and Haymarket Media to distribute podcast episodes as part of Haymarket’s Adv ...

Higher ultraprocessed food intake is associated with greater odds of vascular brain injury and adiposity, but not cognitive performance.

GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.

Symptoms persist or become worse in more than a third of patients hospitalized due to heart failure, research shows.

FibroScan-aspartate aminotransferase may offer the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis.

New guidelines for menopause treatment focus on hormone therapy and managing symptoms like hot flashes, sleep trouble, and depression.

Adding evolocumab to lipid-lowering therapy reduces all-cause mortality in high-risk patients without a history of myocardial infarction or stroke.

Among critically ill patients with acute kidney injury, intermittent hemodialysis as an initial treatment is not noninferior to CRRT.

Gossamer Bio has submitted a New Drug Application to the FDA seeking approval of seralutinib for pulmonary arterial hypertension (PAH).

Global myocarditis cases increased from 1990 to 2023, while age-standardized mortality and disability-adjusted life years saw significant declines.

Post-hoc phase 2 data show coramitug induces an early, transient hsCRP rise followed by a sustained 52-week inflammatory reduction in ATTR-CM.